|
Cardiovascular Pharmacology
Citations 611-620 of 1154 total displayed.
|
Past content
(since Jan 1999):
|
- Clinical Investigations and Reports
Prognostic Impact of Vascular Leakage in Acute Kawasaki Disease
- Masaru Terai, Takafumi Honda, Kumi Yasukawa, Kouji Higashi, Hiromichi Hamada, and Yoichi Kohno
Circulation 2003;108:325-330; published online before print as doi:10.1161/01.CIR.0000079166.93475.5F
[Abstract]
[Full text]
- Basic Science Reports
Partial Agonist Activity of Bucindolol Is Dependent on the Activation State of the Human ß1-Adrenergic Receptor
- Christoph Maack, Michael Böhm, Lydia Vlaskin, Ewtim Dabew, Kristina Lorenz, Hans-Joachim Schäfers, Martin J. Lohse, and Stefan Engelhardt
Circulation 2003;108:348-353; published online before print as doi:10.1161/01.CIR.0000080325.94345.8B
[Abstract]
[Full text]
- Cardiovascular Drugs
Clinical Use of Inotropic Therapy for Heart Failure: Looking Backward or Forward? Part I: Inotropic Infusions During Hospitalization
- Lynne Warner Stevenson
Circulation 2003;108:367-372, doi:10.1161/01.CIR.0000078348.44634.BA
[Full text]
- Articles
Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass Surgery
- N. Zimmermann, A. Wenk, U. Kim, P. Kienzle, A. -A. Weber, E. Gams, K. Schrör, and T. Hohlfeld
Circulation published July 21, 2003, doi:10.1161/01.CIR.0000081770.51929.5A
[Abstract]
- Clinical Investigations and Reports
Efficacy and Safety of Tenecteplase in Combination With the Low-Molecular-Weight Heparin Enoxaparin or Unfractionated Heparin in the Prehospital Setting: The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS Randomized Trial in Acute Myocardial Infarction
- L. Wallentin, P. Goldstein, P.W. Armstrong, C.B. Granger, A.A.J. Adgey, H.R. Arntz, K. Bogaerts, T. Danays, B. Lindahl, M. Mäkijärvi, F. Verheugt, and F. Van de Werf
Circulation 2003;108:135-142; published online before print as doi:10.1161/01.CIR.0000081659.72985.A8
[Abstract]
[Full text]
- Articles
Additive Protection of the Ischemic Heart Ex Vivo by Combined Treatment With  -Protein Kinase C Inhibitor and  -Protein Kinase C Activator
- Koichi Inagaki, Harvey S. Hahn, Gerald W. Dorn, II, and Daria Mochly-Rosen
Circulation published July 14, 2003, doi:10.1161/01.CIR.0000081943.93653.73
[Abstract]
- Clinical Investigations and Reports
Efficacy and Safety of Tenecteplase in Combination With the Low-Molecular-Weight Heparin Enoxaparin or Unfractionated Heparin in the Prehospital Setting: The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS Randomized Trial in Acute Myocardial Infarction
- L. Wallentin, P. Goldstein, P. W. Armstrong, C. B. Granger, A. A.J. Adgey, H. R. Arntz, K. Bogaerts, T. Danays, B. Lindahl, M. Mäkijärvi, F. Verheugt, and F. Van de Werf
Circulation published July 7, 2003, doi:10.1161/01.CIR.0000081659.72985.A8
[Abstract]
[Full text]
- Articles
349Partial Agonist Activity of Bucindolol Is Dependent on the Activation State of the Human  1-Adrenergic Receptor
- Christoph Maack, Michael Böhm, Lydia Vlaskin, Ewtim Dabew, Kristina Lorenz, Hans-Joachim Schäfers, Martin J. Lohse, and Stefan Engelhardt
Circulation published July 7, 2003, doi:10.1161/01.CIR.0000080325.94345.8B
[Abstract]
- Basic Science Reports
Phosphodiesterase Type 5 as a Target for the Treatment of Hypoxia-Induced Pulmonary Hypertension
- A. Sebkhi, Julian W. Strange, Steven C. Phillips, John Wharton, and Martin R. Wilkins
Circulation 2003;107:3230-3235; published online before print as doi:10.1161/01.CIR.0000074226.20466.B1
[Abstract]
[Full text]
- Articles
Prognostic Impact of Vascular Leakage in Acute Kawasaki Disease
- Masaru Terai, Takafumi Honda, Kumi Yasukawa, Kouji Higashi, Hiromichi Hamada, and Yoichi Kohno
Circulation published June 30, 2003, doi:10.1161/01.CIR.0000079166.93475.5F
[Abstract]
|
|
